NAD+ is one of the most intensively studied molecules in longevity and cellular-metabolism research. This article provides an educational overview of what the published scientific literature reports about NAD+, its biological role, and why it has become a major focus of cellular research. All information below is provided strictly for research and informational purposes.
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. Technically it is a dinucleotide rather than a peptide, but it is widely studied alongside peptides in longevity and cellular-research contexts. Research literature describes NAD+ as central to cellular energy metabolism, functioning as a coenzyme in a large number of enzymatic reactions. It is typically supplied as a lyophilised powder for research use.
Mechanisms of interest
Scientific interest in NAD+ centres on its role in core cellular processes. The published literature describes its study in relation to:
- Energy metabolism — NAD+ participates in redox reactions central to the production of ATP, the cell's energy currency, within the mitochondria.
- Sirtuin activity — research examines NAD+ as a required co-substrate for sirtuins, a family of enzymes studied extensively in the context of cellular ageing.
- DNA repair — NAD+ is studied in relation to enzymes (such as PARPs) involved in DNA-repair processes.
- Cellular ageing research — metabolomic studies of ageing have identified NAD+ as a central metabolic intermediate, and research notes that cellular NAD+ levels have been documented to decline with age in study models.
What the research has reported
NAD+ is the subject of a large and active body of research spanning energy metabolism, ageing biology, and cellular repair. Much of the foundational work is preclinical and mechanistic. Researchers note that, despite decades of study, the molecular mechanisms underlying NAD+ metabolism and its precursors are still being characterised, making it a continually evolving area of investigation.
Regulatory status in Australia
As supplied for laboratory research, NAD+ is provided strictly as a research compound. It is not approved by the Therapeutic Goods Administration (TGA) as a therapeutic good for general use and is not intended for human or animal consumption.
Important disclaimer
This article is provided for informational and laboratory-research purposes only. NAD+ is supplied strictly as a research compound, for in-vitro laboratory research use only. It is not for human or animal consumption. Nothing in this article constitutes medical advice, nor a recommendation for use in humans. Always refer to current published literature and applicable regulations.